Microwave accelerated 68Ga-labelling of oligonucleotides

被引:22
作者
Velikyan, I
Lendvai, G
Välilä, M
Roivainen, A
Yngve, U
Bergström, M
Långström, B
机构
[1] Uppsala Imanet, SE-75109 Uppsala, Sweden
[2] Uppsala Univ, Inst Chem, Dept Organ Chem, SE-75121 Uppsala, Sweden
[3] Turku PET Ctr, FIN-20521 Turku, Finland
关键词
Ga-68; radiolabelled antisense oligonucleotides; DOTA; microwave activation;
D O I
10.1002/jlcr.799
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotides are extensively used for characterization of gene expression in vitro and have now been studied as inhibitors of gene expression in vivo in various diseases. Labelled antisense oligonucleotides are therefore of potential interest for possible in vivo imaging of gene expression, considering the biology of tumors and applications in designing novel molecule-targeted therapies. In the present work a method of microwave accelerated Ga-68-labelling of oligonucleotides and analysis of the resulting tracers are described. Four modified and functionalized 17-mer oligonucleotides with a hexylamine group in the 3'- or Y-position were studied. The oligonucleotides were conjugated to the bifunctional chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and then labelled with Ga-68(T-1/2 = 68 min) using microwave activation. The isolated decay-corrected radiochemical yields ranged from 30 to 52%. Labelled products were stable in water and ethanol for more than 4h. The impact of the labelling procedure on the oligonucleotide probes was investigated using hybridization to a complementary 17-mer sense oligonucleotide in solution. Chemical modification did not influence either the labelling or hybridization ability of the oligonucleotides. The radiolabelled oligonucleotides will be used for the further in vitro and in vivo biology studies. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:79 / 89
页数:11
相关论文
共 38 条
[1]   Antisense and/or Immunostimulatory Oligonucleotide Therapeutics [J].
Agrawal, Sudhir ;
Kandimalla, Ekambar R. .
CURRENT CANCER DRUG TARGETS, 2001, 1 (03) :197-209
[2]   ANTISENSE 2'-O-ALKYL OLIGORIBONUCLEOTIDES ARE EFFICIENT INHIBITORS OF REVERSE TRANSCRIPTION [J].
BOIZIAU, C ;
LARROUY, B ;
SPROAT, BS ;
TOULME, JJ .
NUCLEIC ACIDS RESEARCH, 1995, 23 (01) :64-71
[3]   STRUCTURE AND SOLUTION STABILITY OF INDIUM AND GALLIUM COMPLEXES OF 1,4,7-TRIAZACYCLONONANETRIACETATE AND OF YTTRIUM COMPLEXES OF 1,4,7,10-TETRAAZACYCLODODECANETETRAACETATE AND RELATED LIGANDS - KINETICALLY STABLE COMPLEXES FOR USE IN IMAGING AND RADIOIMMUNOTHERAPY - X-RAY MOLECULAR-STRUCTURE OF THE INDIUM AND GALLIUM COMPLEXES OF 1,4,7-TRIAZACYCLONONANE-1,4,7-TRIACETIC ACID [J].
BROAN, CJ ;
COX, JPL ;
CRAIG, AS ;
KATAKY, R ;
PARKER, D ;
HARRISON, A ;
RANDALL, AM ;
FERGUSON, G .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1991, (01) :87-99
[4]   NONENZYMATIC SEQUENCE-SPECIFIC CLEAVAGE OF SINGLE-STRANDED-DNA [J].
CHU, BCF ;
ORGEL, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (04) :963-967
[5]   STABILITY, GA-71 NMR, AND CRYSTAL-STRUCTURE OF A NEUTRAL GALLIUM(III) COMPLEX OF 1,4,7-TRIAZACYCLONONANETRIACETATE - A POTENTIAL RADIOPHARMACEUTICAL [J].
CRAIG, AS ;
PARKER, D ;
ADAMS, H ;
BAILEY, NA .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (23) :1793-1794
[6]  
CROOKE ST, 1992, ANNU REV PHARMACOL, V32, P329
[7]   Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease [J].
Dewanjee, MK ;
Haider, N ;
Narula, J .
JOURNAL OF NUCLEAR CARDIOLOGY, 1999, 6 (03) :345-356
[8]  
DEWANJEE MK, 1993, DIAGN ONCOL, V3, P189
[9]  
Dymov A. M., 1968, ANAL CHEM GALLIUM
[10]   Microwave-enhanced radiochemistry [J].
Elander, N ;
Jones, JR ;
Lu, SY ;
Stone-Elander, S .
CHEMICAL SOCIETY REVIEWS, 2000, 29 (04) :239-249